News September 3, 2019 Scott Frederick, former NEA exec, heads to Sands Capital – Washington Business Journal The move comes as Sands continues to expand its investing approach. (more…) Super User 0 Love0
News September 3, 2019 Healthcare startup Gemstone Biotherapeutics gets Maryland Momentum Fund investment – Technical.ly Baltimore Baltimore-based Gemstone Therapeutics has received $250,000 in a new investment from the Maryland Momentum Fund.… Super User 0 Love0
News September 3, 2019 Taiho Pharmaceutical Invests in New Venture Capital Fund Taiho Pharmaceutical Co., Ltd. (HQ: Tokyo, President and Representative Director: Masayuki Kobayashi) announced on August… Super User 0 Love0
News September 3, 2019 Johns Hopkins is launching an accelerator for student startups – Technical.ly Baltimore As students are returning for the semester at Johns Hopkins University, a new accelerator is… Super User 0 Love0
News September 3, 2019 These Female Executives Set the Standard of Excellence in the Biohealth Capital Region · BioBuzz Liftstream, a U.K.-based executive recruiting firm, released an oft referenced report called “A Public Reality… Super User 0 Love0
News September 3, 2019 Viela Bio clears another hurdle to get rare disease drug to market – Washington Business Journal The rare autoimmune disease compromises the central nervous system. (more…) Super User 0 Love0
News September 3, 2019 4 Reasons to Attend Nation’s Leading Pediatric Innovation Symposium – MedCity News For the third consecutive year, Children’s National Health System is co-locating its annual Symposium with… Super User 0 Love0
News September 3, 2019 Why Charities Are Launching For-Profit Businesses Kenton Lee was traveling through Nairobi when he had, as he says jokingly, “the only… Super User 0 Love0
News September 3, 2019 Atlas Research Releases Yearly Health Care Innovation Impact Report | WashingtonExec Atlas Research released its “Impact Through Innovation” report highlighting how it has helped government improve… Super User 0 Love0
News September 3, 2019 FDA gives fast track status to AstraZeneca’s diabetes drug Farxiga AstraZeneca Plc said on Tuesday that the U.S. Food and Drug Administration has granted fast… Super User 0 Love0